Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Breast Neoplasms 1

Interventions

venetoclax 188 Azacitidine 160 Cytarabine 127 fludarabine 96 Cyclophosphamide 74 Specimen Handling 68 fludarabine phosphate 56 Daunorubicin 53 Biopsy 49 Decitabine 47 Whole-Body Irradiation 42 Mycophenolic Acid 40 Idarubicin 40 Busulfan 37 Tacrolimus 35 Injections 35 Granulocyte Colony-Stimulating Factor 35 Melphalan 32 Stem Cell Transplantation 30 gilteritinib 25 Filgrastim 25 CPX-351 25 decitabine and cedazuridine drug combination 23 Peripheral Blood Stem Cell Transplantation 22 Etoposide 20 Mitoxantrone 19 Cladribine 19 ivosidenib 18 Thiotepa 17 Sirolimus 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Immunotherapy, Active × 1 year × Clear all

NCT07551037 2026-05-01

AML

Fujian Medical University Union Hospital

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡